Skip Navigation


ToxSci Advance Access originally published online on March 22, 2007
Toxicological Sciences 2007 97(2):308-317; doi:10.1093/toxsci/kfm063
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
97/2/308    most recent
kfm063v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by McLanahan, E. D.
Right arrow Articles by Fisher, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McLanahan, E. D.
Right arrow Articles by Fisher, J. W.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Low-Dose Effects of Ammonium Perchlorate on the Hypothalamic-Pituitary-Thyroid Axis of Adult Male Rats Pretreated with PCB126

Eva D. McLanahan*,1, Jerry L. Campbell, Jr*, Duncan C. Ferguson*, Barry Harmon{dagger},2, Joan M. Hedge{ddagger}, Kevin M. Crofton{ddagger}, David R. Mattie§, Lewis Braverman, Deborah A. Keys||, Moiz Mumtaz||| and Jeffrey W. Fisher*

* Interdisciplinary Toxicology Program, University of Georgia, Athens, Georgia 30602 {dagger} Department of Pathology, College of Veterinary Medicine, University of Georgia, Athens, Georgia 30602 {ddagger} Neurotoxicology Division, National Health and Environmental Effects Research Laboratory, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, North Carolina 27711 § Air Force Research Laboratory, Human Effectiveness Directorate, Biosciences and Protection Division, Applied Biotechnology Branch, Wright-Patterson Air Force Base, Ohio 45433 Section of Endocrinology, Diabetes, and Nutrition Center, Boston Medical Center, Boston, Massachusetts 02118 || Statistics and Modeling Supporting Informed Decisions, Athens, Georgia 30606 ||| Division of Toxicology, Agency for Toxic Substances and Disease Registry, Atlanta, Georgia 30333

1 To whom correspondence should be addressed at 206 Environmental Health Sciences Department, University of Georgia, Athens, GA 30602-2102, USA. Fax: 706-542-7472. E-mail: evad{at}uga.edu.

Received January 18, 2007; accepted March 16, 2007


   Abstract

The objective of this research was to characterize the disturbances in the hypothalamic-pituitary-thyroid (HPT) axis resulting from exposure to a binary mixture, 3,3',4,4',5-pentachlorobiphenyl (PCB126) and perchlorate (ClOFormula), known to cause hypothyroidism by different modes of action. Two studies were conducted to determine the HPT axis effects of ClOFormula on adult male Sprague-Dawley rats pretreated with PCB126. In dosing study I, rats were administered a single oral dose of PCB126 (0, 7.5, or 75 µg/kg) on day 0 and 9 days later ClOFormula (0, 0.01, 0.1, or 1 mg/kg day) was added to the drinking water until euthanasia on day 22. Significant dose-dependent trends were found for all thyroid function indices measured following ClOFormula in drinking water for 14 days. Seventy-five micrograms PCB126/kg resulted in a significant increase in hepatic T4-glucuronide formation, causing a decline in serum thyroxine and fT4, and resulting in increased serum thyroid-stimulating hormone (TSH). Serum TSH was also increased in animals that received 7.5 µg PCB126/kg; no other HPT axis alterations were found in these animals. When pretreated with PCB126, the ClOFormula dose trends disappeared, suggesting a less than additive effect on the HPT axis. In dosing study II, animals were given lower doses of PCB126 (0, 0.075, 0.75, or 7.5 µg/kg) on day 0, and followed with ClOFormula (0 or 0.01 mg/kg day) in drinking water beginning on day 1 and continuing for several days to explore transient HPT axis effects. No statistical effects were seen for PCB126 or ClOFormula alone, and no perturbations were found when administered sequentially in dosing study II. In conclusion, these studies demonstrate that HPT axis disturbances following exposure to ClOFormula are less than additive when pretreated with relatively high doses of PCB126. At relatively low doses, at or near the no-observed-effect-level for PCB126 and ClOFormula, no interactions between the chemicals occur.

Key Words: PCB126; perchlorate; rat; T4; thyroid; TSH; UDPGT.


2 Barry Harmon has passed away since submission of this article.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Toxicol SciHome page
E. D. McLanahan, M. E. Andersen, and J. W. Fisher
A Biologically Based Dose-Response Model for Dietary Iodide and the Hypothalamic-Pituitary-Thyroid Axis in the Adult Rat: Evaluation of Iodide Deficiency
Toxicol. Sci., April 1, 2008; 102(2): 241 - 253.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.